OMGAQ (Omega Therapeutics) Total Assets: $152.73 Mil (As of Sep. 2024)


OMGAQ Omega Therapeutics Inc OMGAQ
16 GF Score
Price $0.00
View Full Analysis

What is Omega Therapeutics Total Assets?

Omega Therapeutics OMGAQ +50.00% 16 Total Assets is $152.73 Mil as of Sep. 2024. GuruFocus rates OMGAQ with a GF Score™ of 16/100.

Omega Therapeutics's Total Assets for the quarter that ended in Sep. 2024 was $152.73 Mil.

Total Assets is connected with ROA %. Omega Therapeutics's annualized ROA % for the quarter that ended in Sep. 2024 was -40.99%. Total Assets is also linked to Revenue through Asset Turnover. Omega Therapeutics's Asset Turnover for the quarter that ended in Sep. 2024 was 0.02.

Omega Therapeutics  (OTCPK:OMGAQ) Total Assets Explanation

Total Assets is connected with ROA %.

Omega Therapeutics's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-65.776/( (168.225+152.727)/ 2 )
=-65.776/160.476
=-40.99 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Omega Therapeutics's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=2.612/( (168.225+152.727)/ 2 )
=2.612/160.476
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Omega Therapeutics Total Assets Related Terms

Omega Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Omega Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Therapeutics Total Assets Chart

Omega Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
6.12 28.08 233.33 146.00 204.37

Omega Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 217.81 204.37 183.68 168.23 152.73
OMGAQ
16GF Score
Omega Therapeutics Inc OMGAQ
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Omega Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=58.016+146.35
=204.37

Omega Therapeutics's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=11.543+141.184
=152.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $152.73 Mil mean?
Omega Therapeutics (OMGAQ) has a Total Assets of $152.73 Mil as of Sep. 2024. The total amount of assets as recorded on a company's balance sheet. View historical data on Omega Therapeutics and its competitors.
Is Omega Therapeutics' Total Assets too high?
Omega Therapeutics' current Total Assets is $152.73 Mil. Overall, Omega Therapeutics has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Omega Therapeutics' Total Assets compare to ENDV and ORGS?
Omega Therapeutics' Total Assets of $152.73 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Omega Therapeutics and its competitors. Omega Therapeutics's current Total Assets is $152.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Therapeutics stock overvalued right now?
Omega Therapeutics (OMGAQ) has a current Total Assets of $152.73 Mil. The current Total Assets is $152.73 Mil. Omega Therapeutics' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Omega Therapeutics (OMGAQ), the current Total Assets is $152.73 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omega Therapeutics Business Description

Address 140 First Street, Suite 501, Cambridge, MA, USA, 02141
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
16GF Score

Get the complete analysis for OMGAQ

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price